- December 9, 2016 | BY
Perspective on the debate over regulating stem cell clinics, the launch of CRL’s CRISPR services, a way to end cholera in Haiti.
- December 8, 2016 | BY
The first decline since 1993 is likely being driven by multiple factors, including obesity.
- December 5, 2016 | BY
CRISPR for the development of organoids or PDX, and novel immunomodulatory, combination therapies. What our cancer scientists are eyeing in the coming year.
- December 2, 2016 | BY
The pros and cons of an animal studies database, the latest on three-parent IVF and a crucial vote on the US Cures Act.
- December 1, 2016 | BY
Deep learning’s deepening impact on drug discovery and free energy simulations in industrial computer-aided drug design. What our chemists are looking for in the coming year.
- November 29, 2016 | BY
How much progress are we making toward solving this neurological disorder? Scientists from Charles River Laboratories and Teva Pharmaceuticals discuss the state of the science. Listen and learn.
- November 28, 2016 | BY
Trying to stop genetic manipulation of the human genome is futile, so let’s learn to use it wisely.
- November 25, 2016 | BY
Trial clouds amyloid beta theory, what might be causing food coma, and why yo-yo dieting doesn’t work.
- November 21, 2016 | BY
Diversity-oriented synthesis leads to a promising new compound for the single-dose treatment of malaria.
- November 18, 2016 | BY
How should we deal with the number one risk factor for many diseases? Three scientist discuss the concept of treating aging.